Tiny study could unlock secrets of genetic heart failure
NCT ID NCT07646600
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 10 Chinese adults who have a specific gene mutation (BAG3) linked to dilated cardiomyopathy, a condition where the heart becomes enlarged and weak. Researchers will track changes in heart function, symptoms, and biomarkers over time to better understand how the disease progresses. The goal is to identify unmet medical needs and potential ways to measure treatment effects in future drug trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help researchers better understand how this genetic heart condition progresses and identify new targets for future treatments.
- What could go wrong
- This is a very small observational study with only 10 participants, so findings may not apply to all patients. It does not test any treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BAG3 GENE MUTATION-ASSOCIATED DILATED CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart scans may soon replace Needle-Based catheter tests
- Heart conditions in kids: study reveals impact on daily life and play
- Gene hunt launched for kids with heart muscle disease
- MRI scans could help decide who needs a heart defibrillator
- AI-Powered patch could replace ultrasound for heart checkups
- Heart condition costs under the microscope in massive hospital study